Clinical Trial Finds Cannabis Extract With THC and CBD Improves Cognitive Function in Patients With Alzheimer’s-Related Dementia
A phase 2 clinical trial published in the Journal of Alzheimer’s Disease suggests that low-dose THC-CBD extract may improve cognitive function in patients with Alzheimer’s-related dementia.
“We designed this trial to evaluate the safety and efficacy of low-dose THC-CBD balanced cannabinoid extract in the treatment of patients with AD-associated dementia”
The research team, consisting of members from the Johns Hopkins School of Medicine, the Universidade Federal do Rio Grande do Sul, and the Universidade Federal da Integração Latino-Americana, conducted a randomized, double-blind, placebo-controlled study.
- Participants were aged 60 to 80
- Had been diagnosed with Alzheimer’s dementia
The study was also published online by the U.S.
Author's summary: Cannabis extract improves cognitive function.